Our Global Footprint

Our dedication to enriching lives worldwide through quality products calls for zero compromises. Our offices in over 40 countries, 17 state-of-the-art manufacturing facilities and 5 R&D centers worldwide, help us work relentlessly towards making a transformational difference to lives of patients across the globe.

Our commercial presence in over 80 countries across 5 continents and in major markets such as India, US, EU, Brazil and Russia has enabled us to leverage our infrastructure globally as well as market innovative products that meet medical needs worldwide.

We cater to the developed economies of US and Europe through our generics business, as well as the emerging economies of India, Russia and Brazil through our branded generics business. Over 70% per cent of our revenue is contributed by operations outside India.

Our scientists constantly endeavor towards creating centers of excellence in dermatology, oncology and respiratory therapy across the 5 R&D centers in India and Switzerland and finding solutions that contribute to enriching lives globally.

NEW MANUFACTURING FACILITY IN NORTH CAROLINA, US We have expanded our geographical footprint by establishing a new manufacturing facility in the key strategic market of North America which is in the final phase of going fully operational. This formulations plant in Monroe, North Carolina is spread over 100,000 sq. ft. and will manufacture oral solids and injectables and the plans are to add new dosage forms in the near future. The facility dedicated exclusively to the US market will help us to serve our growing business in the country.